Home | Welcome to Contract Pharma   
Last Updated Friday, September 19 2014
Print RSS Feed

Breaking News

Related Searches:
December 15, 2010
Anthera Pharmaceuticals has selected the Merck BioManufacturing Network to manufacture the large-scale GMP clinical and pre-commercial supplies of A-623, an investigational peptibody in development for autoimmune diseases.  Read More »
December 15, 2010
DSM Pharmaceutical Products has entered a license agreement with c-LEcta GmbH for its alcohol dehydrogenases screening technology for enzyme screening programs and development of sustainable manufacturing routes for pharmaceutical active ingredients and i  Read More »
December 14, 2010
Charles River Laboratories International, Inc. released its business outlook, highlighting its portfolio and its plan to focus on four key initiatives in an effort to drive shareholder value.  Read More »
December 14, 2010
Kathleen P. Bloch has been appointed chief financial officer of Laureate Pharma.   Read More »
December 14, 2010
INC Research, LLC has moved its headquarters into new offices in Raleigh, NC.  Read More »
December 13, 2010
Sartorius Stedim Systems GmbH, a subsidiary of Sartorius Stedim Biotech (SSB), is expanding its capacity and optimizing its production operations by combining its work and production areas.  Read More »
December 13, 2010
Inno Biologics has delivered the first batch of clinical grade biopharma material made in Malaysia and entered into its first agreement to commercially manufacture biosimilars for Avesthagen Ltd., a life science company based in India.  Read More »
December 13, 2010
PharmaNet Development Group is launching two technology platforms, Initiator and PKS, aimed at providing significant improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinic  Read More »
December 13, 2010
Tanabe Research Laboratories, Inc. (TRL) has entered into a partnership with Anaphore, Inc. for the research and preclinical development of novel protein therapies for autoimmune diseases based on Anaphore's Atrimer technology.  Read More »
December 10, 2010
Pfizer is voluntarily withdrawing Thelin (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in the EU, Canada and Australia, where the drug is approved.  Read More »
December 10, 2010
MorphoSys AG has signed a non-exclusive license and technology transfer agreement between its subsidiary Sloning BioTechnology GmbH and Pfizer.   Read More »
December 10, 2010
Genentech, a member of the Roche Group, achieved positive results from a Phase II study evaluating a combination of pertuzumab and Herceptin plus chemotherapy in women with early-stage, HER2-positive breast cancer.  Read More »
December 9, 2010
Catalent Pharma Solutions has appointed Scott Neilson as vice president of Operations Development, Elaine Dymond as vice president of Quality, Ronald Overhiser as vice president of Innovation Operations, and Evjatar Cohen as vice president of Portfolio Ma  Read More »
December 9, 2010
Scott Knorr has been appointed vice president and general manager of Adhesives Research, Inc.’s Adhesives Research division.   Read More »
December 9, 2010
Howard Moody has been appointed chief information officer and Alan Findlater has been appointed chief commercial officer of WIL Research Co.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On